Cargando…
Autotaxin in Pathophysiology and Pulmonary Fibrosis
Lysophospholipid signaling is emerging as a druggable regulator of pathophysiological responses, and especially fibrosis, exemplified by the relative ongoing clinical trials in idiopathic pulmonary fibrosis (IPF) patients. In this review, we focus on ectonucleotide pyrophosphatase-phosphodiesterase...
Autores principales: | Ninou, Ioanna, Magkrioti, Christiana, Aidinis, Vassilis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008954/ https://www.ncbi.nlm.nih.gov/pubmed/29951481 http://dx.doi.org/10.3389/fmed.2018.00180 |
Ejemplares similares
-
The Role of Autotaxin and LPA Signaling in Embryonic Development, Pathophysiology and Cancer
por: Magkrioti, Christiana, et al.
Publicado: (2023) -
Genetic deletion of Autotaxin from CD11b(+) cells decreases the severity of experimental autoimmune encephalomyelitis
por: Ninou, Ioanna, et al.
Publicado: (2020) -
Autotaxin and Endotoxin-Induced Acute Lung Injury
por: Mouratis, Marios-Angelos, et al.
Publicado: (2015) -
Autotaxin Activity in Chronic Subdural Hematoma: A Prospective Clinical Study
por: Kalamatianos, Theodosis, et al.
Publicado: (2022) -
A role for bronchial epithelial autotaxin in ventilator-induced lung injury
por: Nikitopoulou, Ioanna, et al.
Publicado: (2021)